What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations

被引:33
作者
Denker, Matthew G. [1 ]
Cohen, Debbie L. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
hypertension; blood pressure target; antihypertensive treatment; elderly; ISOLATED SYSTOLIC HYPERTENSION; NUTRITION EXAMINATION SURVEY; PEOPLE AGED 85; NATIONAL-HEALTH; ANTIHYPERTENSIVE DRUGS; ANGIOTENSIN-II; CARDIOVASCULAR EVENTS; RANDOMIZED-TRIAL; ACTIVE TREATMENT; SWEDISH TRIAL;
D O I
10.2147/CIA.S33087
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Hypertension is common in the elderly, and isolated systolic hypertension is responsible for the majority of hypertension in this population. Hypertension in the elderly can be attributed to numerous structural and functional changes to the vasculature that develop with advancing age. Increased systolic blood pressure is associated with adverse outcomes, including stroke, cardiovascular disease, and death. Some studies demonstrate an inverse relationship between cardiovascular outcomes and diastolic blood pressure whereas other studies show a J-shaped or U-shaped association between blood pressure and outcomes. The complex J-shaped association coupled with the unique characteristics of elderly patients have led to much debate and confusion regarding the treatment of hypertension in this population. Clinical trials indicate a benefit to therapy in older adults, and there appears to be no age threshold above which antihypertensive therapy should be withheld. Treatment of hypertension in elderly patients is further complicated by increased susceptibility to brain hypoperfusion with orthostatic hypotension as well as the risk of drug-drug interactions. We recommend a systolic blood pressure goal of <140 mmHg in patients less than 80 years of age and a systolic blood pressure goal of 140-150 mmHg in patients 80 years of age or older. Reduction of blood pressure is probably more important than the specific agent used and initiation of drug therapy with an angiotensin converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker, or diuretic are all reasonable options, and the decision should be individualized based on underlying comorbidities.
引用
收藏
页码:1505 / 1517
页数:13
相关论文
共 68 条
[1]  
AMERY A, 1985, LANCET, V1, P1349
[2]  
[Anonymous], 1991, JAMA, V265, P3255
[3]  
Antihypertensive T., 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]
[4]   Effects of reduced sodium intake on hypertension control in older individuals -: Results from the trial of nonpharmacologic interventions in the elderly (TONE) [J].
Appel, LJ ;
Espeland, MA ;
Easter, L ;
Wilson, AC ;
Folmar, S ;
Lacy, CR .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (05) :685-693
[5]   ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Aronow, Wilbert S. ;
Fleg, Jerome L. ;
Pepine, Carl J. ;
Artinian, Nancy T. ;
Bakris, George ;
Brown, Alan S. ;
Ferdinand, Keith C. ;
Forciea, Mary Ann ;
Frishman, William H. ;
Jaigobin, Cheryl ;
Kostis, John B. ;
Mancia, Giuseppi ;
Oparil, Suzanne ;
Ortiz, Eduardo ;
Reisin, Efrain ;
Rich, Michael W. ;
Schocken, Douglas D. ;
Weber, Michael A. ;
Wesley, Deborah J. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bhatt, Deepak L. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Fisher, John D. ;
Gardner, Timothy J. ;
Gentile, Federico ;
Gilson, Michael F. ;
Hlatky, Mark A. ;
Jacobs, Alice K. ;
Kaul, Sanjay ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
CIRCULATION, 2011, 123 (21) :2434-2506
[6]   J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial† [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Wun, Chuan-Chuan ;
Zuckerman, Andrea L. ;
DeMicco, David ;
Kostis, John B. ;
LaRosa, John C. .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2897-2908
[7]   Protective effect of long-term angiotensin II inhibition [J].
Basso, Nidia ;
Cini, Rosa ;
Pietrelli, Adriana ;
Ferder, Leon ;
Terragno, Norberto A. ;
Inserra, Felipe .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (03) :H1351-H1358
[8]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898
[9]   Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease [J].
Berry, C ;
Anderson, N ;
Kirk, AJB ;
Dominiczak, AF ;
McMurray, JJV .
HEART, 2001, 86 (02) :217-218
[10]   Blood pressure and mortality in elderly people aged 85 and older: community based study [J].
Boshuizen, HC ;
Izaks, GJ ;
van Buuren, S ;
Ligthart, GJ .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7147) :1780-+